Why the study?
Does BQ-123 (a selective ET(A) receptor antagonist) alter coronary blood flow and artery diameter in patients undergoing coronary arteriography?
Population
22 subjects undergoing diagnostic coronary arteriography, mean age 53 years.
Comparison
BQ-123 (selective ET receptor antagonist; 100… vs 0.9% saline alone infused into the left coronary…
Design
Other
Follow-up
60 minutes
Authors
Loading...
Supports ET(A) blockade modulating basal coronary tone in patients; leaves open therapeutic potential pending randomized trials.
Does BQ-123 (a selective ET(A) receptor antagonist) alter coronary blood flow and artery diameter in patients undergoing coronary arteriography?
Selective ET(A) receptor blockade with BQ-123 causes coronary vasodilation and increases blood flow, demonstrating that endogenous endothelin-1 maintains basal coronary tone.
Zenon S. Kyriakides (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: